Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (2)

Search Parameters:
Keywords = Marcus Fisher

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
37 pages, 9859 KiB  
Article
What Is It Like for You? Rethinking Voice Appropriation in Parafictional Identities in Israeli Art
by Keren Goldberg
Arts 2023, 12(1), 27; https://doi.org/10.3390/arts12010027 - 3 Feb 2023
Viewed by 3248
Abstract
The article focuses on two parafictional figures created by Israeli artists at about the same time in the early 2000s: Oreet Ashery’s Marcus Fisher and Roee Rosen’s Justine Frank. Through a close reading of these case studies, I examine the phenomenon of parafictional [...] Read more.
The article focuses on two parafictional figures created by Israeli artists at about the same time in the early 2000s: Oreet Ashery’s Marcus Fisher and Roee Rosen’s Justine Frank. Through a close reading of these case studies, I examine the phenomenon of parafictional characters as extreme cases of voice appropriation. Against the background of rising international concern with cultural appropriation, and of the Israeli sociopolitical context characterized by a multiplicity of often conflicting identities, I argue that such appropriation is, in fact, a basic aesthetic procedure. Using Hannah Arendt’s reading of Immanuel Kant’s aesthetic judgment as political judgment, and her articulation of an “enlarged mentality” as necessary for both aesthetic and political thinking, the article demonstrates how the ability to imagine a position different from your own is inherent for aesthetic representation as well as reception. Full article
Show Figures

Figure 1

9 pages, 4098 KiB  
Brief Report
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera
by Yfat Yahalom-Ronen, Noam Erez, Morly Fisher, Hadas Tamir, Boaz Politi, Hagit Achdout, Sharon Melamed, Itai Glinert, Shay Weiss, Inbar Cohen-Gihon, Ofir Israeli, Marina Izak, Michal Mandelboim, Yoseph Caraco, Noa Madar-Balakirski, Adva Mechaly, Eilat Shinar, Ran Zichel, Daniel Cohen, Adi Beth-Din, Anat Zvi, Hadar Marcus, Tomer Israely and Nir Paranadd Show full author list remove Hide full author list
Vaccines 2022, 10(2), 291; https://doi.org/10.3390/vaccines10020291 - 14 Feb 2022
Cited by 19 | Viewed by 4326
Abstract
The emergence of rapidly spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a major challenge to the ability of vaccines and therapeutic antibodies to provide immunity. These variants contain mutations of specific amino acids that might impede vaccine efficacy. BriLife [...] Read more.
The emergence of rapidly spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a major challenge to the ability of vaccines and therapeutic antibodies to provide immunity. These variants contain mutations of specific amino acids that might impede vaccine efficacy. BriLife® (rVSV-ΔG-spike) is a newly developed SARS-CoV-2 vaccine candidate currently in phase II clinical trials. It is based on a replication-competent vesicular stomatitis virus (VSV) platform. The rVSV-ΔG-spike contains several spontaneously acquired spike mutations that correspond to SARS-CoV-2 variants’ mutations. We show that human sera from BriLife® vaccinees preserve comparable neutralization titers towards alpha, gamma, and delta variants and show less than a three-fold reduction in the neutralization capacity of beta and omicron compared to the original virus. Taken together, we show that human sera from BriLife® vaccinees overall maintain a neutralizing antibody response against all tested variants. We suggest that BriLife®-acquired mutations may prove advantageous against future SARS-CoV-2 VOCs. Full article
(This article belongs to the Special Issue Effectiveness, Safety and Immunogenicity of SARS-CoV-2 Vaccines)
Show Figures

Figure 1

Back to TopTop